Skip to content
Boston Health Longevity

Stem Cell Therapy for Type 2 Diabetes Support in Thailand

A regenerative approach to improving metabolic function and insulin sensitivity

Apply for Assessment No-obligation consultation
Clinician-Led
International Patients
Competitive Pricing
Testimonials →

Understanding Type 2 Diabetes Support

Type 2 diabetes is a progressive metabolic disorder characterised by insulin resistance and declining beta-cell function in the pancreas. Over time, chronic hyperglycaemia leads to systemic complications including cardiovascular disease, neuropathy, nephropathy, and retinopathy. Mesenchymal stem cells have demonstrated the potential to improve insulin sensitivity, reduce chronic inflammation associated with metabolic dysfunction, and support pancreatic tissue health in preclinical and early clinical research. Stem cell therapy may offer a complementary regenerative approach alongside conventional diabetes management. Treatment is delivered at Boston Health Longevity in Chiang Mai with comprehensive metabolic assessment and monitoring.

Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.

What Causes Type 2 Diabetes Support?

Insulin resistance, where the body's cells become progressively less responsive to insulin, forces the pancreas to produce ever-increasing amounts of insulin until beta-cell exhaustion occurs.

Excess visceral fat, particularly around the abdomen and internal organs, releases inflammatory cytokines and free fatty acids that directly impair insulin signalling and promote metabolic dysfunction.

Genetic predisposition plays a significant role, with family history of diabetes substantially increasing risk. Multiple genes involved in insulin production and glucose metabolism contribute to susceptibility.

Chronic low-grade inflammation (metabolic inflammation) driven by obesity, poor diet, and sedentary lifestyle creates a self-perpetuating cycle of insulin resistance and metabolic deterioration.

Progressive pancreatic beta-cell decline occurs over years as the cells producing insulin become exhausted, damaged by glucotoxicity and lipotoxicity, and eventually fail to meet the body's insulin demands.

Common Signs and Symptoms

Elevated blood glucose levels that may initially be asymptomatic, often discovered incidentally during routine blood tests. By the time symptoms appear, significant metabolic damage may have already occurred.

Increased thirst and frequent urination as the kidneys work to filter excess glucose from the blood, creating a cycle of dehydration and fluid replacement.

Fatigue and low energy levels despite adequate rest, reflecting the cells' inability to efficiently access glucose for energy production due to insulin resistance.

Blurred vision from fluctuating blood sugar levels affecting the lens of the eye, which may be an early warning sign of the microvascular damage diabetes causes.

Slow wound healing and increased susceptibility to infections, particularly skin and urinary tract infections, as elevated glucose impairs immune function and tissue repair.

Numbness, tingling, or burning sensations in the feet and hands (peripheral neuropathy), often the first noticeable complication of poorly controlled blood sugar over time.

Living With Type 2 Diabetes Support

Living with type 2 diabetes means navigating a relentless daily routine of blood sugar monitoring, medication management, and dietary restriction that never takes a day off. You may feel trapped in a cycle where your body seems to work against you despite your best efforts, watching your HbA1c creep upward while adding yet another medication to an already complex regimen. The fear of complications, losing your eyesight, developing kidney failure, or facing amputation, weighs heavily. Social situations become minefields of food choices and explanations, and the constant self-monitoring can feel exhausting. If you are reading this, you may be someone who has followed every recommendation, taken every medication, and still feels that your diabetes is progressing beyond your control.

Conventional Treatment Options

Conventional type 2 diabetes management follows a stepwise approach: lifestyle modification (diet and exercise), metformin as first-line medication, followed by the progressive addition of sulfonylureas, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and ultimately insulin therapy as beta-cell function declines. While these medications effectively lower blood glucose, they do not halt the progressive nature of the disease. Metformin may cause gastrointestinal side effects, sulfonylureas carry hypoglycaemia risk and may accelerate beta-cell burnout, and insulin therapy requires injection and careful dose titration. The newer GLP-1 agonists and SGLT2 inhibitors offer cardiovascular benefits but come with significant cost and their own side effect profiles. For many patients, the trajectory remains one of escalating medication complexity, increasing side effects, and eventual reliance on insulin, driving interest in regenerative approaches that might address the underlying metabolic dysfunction.

If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.

Is It Right For You?

Good Candidates

Patients with type 2 diabetes who have not achieved adequate glycaemic control despite optimised conventional therapy may be candidates. Ideal candidates have residual beta-cell function and are motivated to improve metabolic health through a multimodal approach. A thorough metabolic assessment including HbA1c, C-peptide levels, and cardiovascular risk profiling is required before treatment.

Contraindications

Type 1 diabetes or advanced type 2 with complete beta-cell failure
Active diabetic ketoacidosis or hyperosmolar state
Severe uncontrolled cardiovascular disease
Active systemic infection or sepsis
Active malignancy requiring ongoing treatment
2025 Outcome Data

Clinical outcomes for type 2 diabetes support

Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.

48%

Marker Improvement

Average improvement in metabolic health markers including insulin sensitivity

35%

Medication Reduction

Patients able to reduce metabolic medications under physician supervision

3-6 mo

Response Timeline

Typical period for metabolic improvements to become measurable in blood panels

74%

Patient Satisfaction

Patients reporting improved energy, metabolic health, and overall wellbeing

Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.

How Stem Cell Therapy May Help

May support improved insulin sensitivity and glucose metabolism
Anti-inflammatory properties targeting chronic metabolic inflammation
Potential to support pancreatic beta-cell function preservation
May reduce systemic oxidative stress associated with hyperglycaemia
Complementary approach alongside conventional diabetes management
Personalised protocol based on metabolic profiling and disease severity
Why Thailand

Why Patients Choose Thailand for Type 2 Diabetes Support Treatment

1

Regenerative stem cell therapy for metabolic conditions is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.

2

Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.

3

Transparent pricing with no hidden fees. Metabolic stem cell therapy ranges from $20,000 to $40,000 USD, a fraction of the lifetime cost of escalating diabetes medications and management of complications.

4

Comprehensive metabolic profiling is included as part of the treatment programme, often providing a more thorough assessment than patients receive in their routine diabetes care at home.

5

Structured follow-up care at 1, 3, 6, and 12 months post-treatment with remote metabolic marker tracking ensures your glucose control and metabolic health are monitored objectively over time.

Treatment Comparison

Alternatives to long-term insulin therapy for type 2 diabetes

Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.

Factor Stem Cell Therapy Conventional / Surgery
Typical Cost (Thailand) $20,000 - $40,000 N/A (ongoing medication costs)
Recovery Time Varies by protocol Ongoing daily management
Invasiveness Minimally invasive infusion Daily medication / insulin injections
Hospital Stay 3-4 days outpatient Outpatient (ongoing prescriptions)
Risk Level Low (cell-based, minimal side effects) Variable (hypoglycaemia, medication side effects)
Return to Normal Activity Varies by protocol Continuous management required

Treatment at Boston Health Longevity

$20,000 - $40,000

USD equivalent, personalised to your case

vs Home Country

N/A (ongoing medication costs)

Internationally competitive pricing, same clinical standard

Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.

Wondering if you're a candidate?

Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.

Request Assessment

Trusted by international patients from 11+ countries worldwide

Your Journey

What to expect

1

Remote consultation with comprehensive metabolic history review

2

Arrive in Chiang Mai, logistics and accommodation guidance provided

3

Day 1: Full metabolic panel, cardiovascular assessment, and body composition analysis

4

Day 2: Stem cell preparation and tailored administration protocol

5

Day 3-4: Monitoring, nutritional guidance, and discharge planning

6

Structured remote follow-up at 1, 3, 6, and 12 months with metabolic markers tracking

Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →

Frequently Asked Questions

Can stem cell therapy cure type 2 diabetes?
No. Stem cell therapy is not a cure for type 2 diabetes. It is an emerging regenerative approach that may help improve insulin sensitivity and support metabolic function alongside conventional treatment. We are transparent about realistic expectations.
Will I be able to reduce my diabetes medications?
Any medication adjustments are made cautiously and only under medical supervision in coordination with your treating physician at home. Some patients may see improvements in metabolic markers over time, but this varies by individual.
What type of stem cells are used?
We use mesenchymal stem cells (MSCs) which have demonstrated immunomodulatory and metabolic support properties in published research. The specific protocol is determined during your comprehensive assessment.
How long before I see results?
Metabolic improvements are typically gradual, with changes in markers like fasting glucose and HbA1c assessed at 3 and 6-month follow-ups. Individual responses vary significantly based on disease duration and severity.
Next Steps

Ready to explore type 2 diabetes support treatment?

Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.

Most patients receive their initial assessment within 24 hours.

1

Submit Your Case

Share your medical history and imaging for review.

2

Clinical Assessment

Our team reviews your case and provides an honest recommendation.

3

Treatment Plan

Receive a personalised plan with transparent pricing.

Related Conditions

Other conditions we treat

Medical Disclaimer

The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.

Take the first step

Request a no-obligation assessment for type 2 diabetes support treatment at Boston Health Longevity in Chiang Mai.

52

Conditions Treated

11

Countries Served

GMP

Certified Supply

Request Assessment

Every case personally reviewed by our clinical team within 24 hours

Apply for Consultation